Interaction ID
ncRI-40640352
Interaction Molecules
hsa-miR-381-3p -- YTHDC1
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
TargetScan with Ago CLIP data
Tags
Organism
Homo sapiens
Tissue or Cell Type
T-REx-293T;Cingulategyrus
Experiment
AGO CLIP
Description
Conserved miRNAs target sites predicted by TargetScan and miRanda overlap with the AGO CLIP dataset
Alias
-
Class
mRNA
Ensembl id
ENSG00000083896
Description
Regulator of alternative splicing that specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs (PubMed:26318451, PubMed:26876937, PubMed:25242552, PubMed:28984244). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in the efficiency of mRNA splicing, processing and stability (PubMed:26318451, PubMed:25242552). Acts as a key regulator of exon-inclusion or exon-skipping during alternative splicing via interaction with mRNA splicing factors SRSF3 and SRSF10 (PubMed:26876937). Specifically binds m6A-containing mRNAs and promotes recruitment of SRSF3 to its mRNA-binding elements adjacent to m6A sites, leading to exon-inclusion during alternative splicing (PubMed:26876937). In contrast, interaction with SRSF3 prevents interaction with SRSF10, a splicing factor that promotes exon skipping: this prevents SRSF10 from binding to its mRNA-binding sites close to m6A-containing regions, leading to inhibit exon skipping during alternative splicing (PubMed:26876937). May also regulate alternative splice site selection (PubMed:20167602). Also involved in nuclear export of m6A-containing mRNAs via interaction with SRSF3: interaction with SRSF3 facilitates m6A-containing mRNA-binding to both SRSF3 and NXF1, promoting mRNA nuclear export (PubMed:28984244). Also recognizes and binds m6A on other RNA molecules (PubMed:27602518). Involved in random X inactivation mediated by Xist RNA: recognizes and binds m6A-containing Xist and promotes transcription repression activity of Xist (PubMed:27602518). Involved in S- adenosyl-L-methionine homeostasis by regulating expression of MAT2A transcripts, probably by binding m6A-containing MAT2A mRNAs (By similarity).
Pubmed ID | 24389009 | Journal | Neuron |
---|---|---|---|
Title | Transcriptome-wide discovery of microRNA binding sites in human brain. | ||
Author | Boudreau RL, Jiang P, Gilmore BL, Spengler RM, Tirabassi R, Nelson JA, Ross CA, Xing Y, Davidson BL |
Pubmed ID | 29273203 | Journal | Journal of molecular biology |
---|---|---|---|
Title | Transcriptome-wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. | ||
Author | Li Y, Estep JA, Karginov FV |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-381-3p | acromegaly | MNDR Database |
hsa-miR-381-3p | adrenocortical carcinoma | MNDR Database |
hsa-miR-381-3p | Alzheimer's disease | MNDR Database |
hsa-miR-381-3p | amyotrophic lateral sclerosis | MNDR Database |
hsa-miR-381-3p | autism spectrum disorder | MNDR Database |
hsa-miR-381-3p | autistic disorder | MNDR Database |
hsa-miR-381-3p | autosomal recessive limb-girdle muscular dystrophy type 2A | MNDR Database |
hsa-miR-381-3p | autosomal recessive limb-girdle muscular dystrophy type 2B | MNDR Database |
hsa-miR-381-3p | Barrett's adenocarcinoma | MNDR Database |
hsa-miR-381-3p | bladder urothelial carcinoma | MNDR Database |
hsa-miR-381-3p | bone disease | MNDR Database |
hsa-miR-381-3p | brain disease | MNDR Database |
hsa-miR-381-3p | breast cancer | MNDR Database |
hsa-miR-381-3p | Breast Neoplasms | MNDR Database |
hsa-miR-381-3p | cancer | MNDR Database |
hsa-miR-381-3p | carcinoma | MNDR Database |
hsa-miR-381-3p | Carcinoma, Ductal, Breast | MNDR Database |
hsa-miR-381-3p | Carcinoma, Renal Cell | MNDR Database |
hsa-miR-381-3p | cervical squamous cell carcinoma | MNDR Database |
hsa-miR-381-3p | cholangiocarcinoma | MNDR Database |
hsa-miR-381-3p | chronic fatigue syndrome | MNDR Database |
hsa-miR-381-3p | colon cancer | MNDR Database |
hsa-miR-381-3p | colorectal cancer | MNDR Database |
hsa-miR-381-3p | dermatomyositis | MNDR Database |
hsa-miR-381-3p | dilated cardiomyopathy | MNDR Database |
hsa-miR-381-3p | distal muscular dystrophy | MNDR Database |
hsa-miR-381-3p | Duchenne muscular dystrophy | MNDR Database |
hsa-miR-381-3p | esophageal cancer | MNDR Database |
hsa-miR-381-3p | esophageal carcinoma | MNDR Database |
hsa-miR-381-3p | familiar ovarian carcinoma | MNDR Database |
hsa-miR-381-3p | fragile X syndrome | MNDR Database |
hsa-miR-381-3p | gastric adenocarcinoma | MNDR Database |
hsa-miR-381-3p | Glioblastoma | MNDR Database |
hsa-miR-381-3p | Growth Hormone-Secreting Pituitary Adenoma | MNDR Database |
hsa-miR-381-3p | head and neck squamous cell carcinoma | MNDR Database |
hsa-miR-381-3p | Heart Failure | MNDR Database |
hsa-miR-381-3p | hepatocellular carcinoma | MNDR Database |
hsa-miR-381-3p | Her2-receptor positive breast cancer | MNDR Database |
hsa-miR-381-3p | Huntington's disease | MNDR Database |
hsa-miR-381-3p | inclusion body myositis | MNDR Database |
hsa-miR-381-3p | intellectual disability | MNDR Database |
hsa-miR-381-3p | leukemia | MNDR Database |
hsa-miR-381-3p | liposarcoma | MNDR Database |
hsa-miR-381-3p | lung adenocarcinoma | MNDR Database |
hsa-miR-381-3p | lung cancer | MNDR Database |
hsa-miR-381-3p | lung small cell carcinoma | MNDR Database |
hsa-miR-381-3p | lung squamous cell carcinoma | MNDR Database |
hsa-miR-381-3p | lupus nephritis | MNDR Database |
hsa-miR-381-3p | lymphoma | MNDR Database |
hsa-miR-381-3p | major depressive disorder | MNDR Database |
hsa-miR-381-3p | malignant glioma | MNDR Database |
hsa-miR-381-3p | melanoma | MNDR Database |
hsa-miR-381-3p | Muscular Disorders, Atrophic | MNDR Database |
hsa-miR-381-3p | Myotonic Dystrophy | MNDR Database |
hsa-miR-381-3p | nemaline myopathy | MNDR Database |
hsa-miR-381-3p | nephroblastoma | MNDR Database |
hsa-miR-381-3p | neurodegenerative disease | MNDR Database |
hsa-miR-381-3p | oral squamous cell carcinoma | MNDR Database |
hsa-miR-381-3p | osteosarcoma | MNDR Database |
hsa-miR-381-3p | ovarian carcinoma | MNDR Database |
hsa-miR-381-3p | ovarian clear cell carcinoma | MNDR Database |
hsa-miR-381-3p | Ovarian Neoplasms | MNDR Database |
hsa-miR-381-3p | pancreatic cancer | MNDR Database |
hsa-miR-381-3p | pancreatic ductal adenocarcinoma | MNDR Database |
hsa-miR-381-3p | papillary renal cell carcinoma | MNDR Database |
hsa-miR-381-3p | pituitary adenoma | MNDR Database |
hsa-miR-381-3p | progesterone-receptor negative breast cancer | MNDR Database |
hsa-miR-381-3p | progesterone-receptor positive breast cancer | MNDR Database |
hsa-miR-381-3p | prostate adenocarcinoma | MNDR Database |
hsa-miR-381-3p | psoriasis | MNDR Database |
hsa-miR-381-3p | pulmonary tuberculosis | MNDR Database |
hsa-miR-381-3p | rectum adenocarcinoma | MNDR Database |
hsa-miR-381-3p | renal cell carcinoma | MNDR Database |
hsa-miR-381-3p | renal clear cell carcinoma | MNDR Database |
hsa-miR-381-3p | stomach cancer | MNDR Database |
hsa-miR-381-3p | Stroke, Lacunar | MNDR Database |
hsa-miR-381-3p | systemic mastocytosis | MNDR Database |
hsa-miR-381-3p | thyroid cancer | MNDR Database |
hsa-miR-381-3p | thyroid carcinoma | MNDR Database |
hsa-miR-381-3p | tonsil cancer | MNDR Database |
hsa-miR-381-3p | urinary bladder cancer | MNDR Database |
hsa-miR-381-3p | uterine cancer | MNDR Database |
hsa-miR-381-3p | uterine corpus endometrial carcinoma | MNDR Database |
hsa-miR-381-3p | vascular disease | MNDR Database |